Literature DB >> 172473

Spontaneous interferon production and Epstein-barr virus antigen expression in two human lymphoid cell lines and their somatic cell hybrids.

B Lidin, A Adams.   

Abstract

Two human lymphoid cell lines, Raji and Namalwa, and seven somatic cell hybrids between these two cells were tested for spontaneous interferon production. Namalwa and three of the hybrids produce interferon while the four other hybrids, like Raji, do not. Though the Namalwa line is relatively resistant to superinfection with the Epstein-Barr virus (EBV), all hybrids are as susceptible to EBV as the Raji parent. High extracellular concentrations of interferon likewise had little effect on EBV superinfection of Raji or the hybrid cells and it is possible that Raji produces some factor that antagonizes the action of interferon to allow virus expression.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172473     DOI: 10.1159/000149897

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  5 in total

1.  Spontaneous production of human interferon.

Authors:  L A Pickering; L H Kronenberg; W E Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

2.  Antigenic properties of human lymphoblastoid interferons.

Authors:  B J Dalton; K Paucker
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Antiviral effects of interferon on a somatic cell hybrid between two Burkitt's lymphoma cell lines of different interferon sensitivities.

Authors:  B Lidin; E W Lamon
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  Spontaneous production of alpha- and beta-interferon in human lymphoblastoid and lymphoma cell lines.

Authors:  G R Adolf; O A Haas; P Fischer; P Swetly
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects.

Authors:  Hin Kwok; Koon Wing Chan; Kwok Hung Chan; Alan Kwok Shing Chiang
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.